UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000026046
Receipt number R000029875
Scientific Title Phase Ib/II study to assess efficacy, safety & immunological biomarker of anti PD-1 antibody with radiation therapy in patients with HER-2-negative metastatic breast cancer
Date of disclosure of the study information 2017/02/08
Last modified on 2024/02/19 13:54:05

No. Disposal Last modified on Item of update
1 Insert 2017/02/08 12:13:11
2 Update 2017/02/08 14:05:46 Recruitment status
3 Update 2018/03/02 19:25:46 Anticipated trial start date
4 Update 2018/04/09 16:01:48 Division name
Division name
TEL
Organization
Organization
Division name
Division name
Address
TEL
Institute
Institute
5 Update 2018/08/10 17:38:23 Recruitment status
Last follow-up date
6 Update 2018/08/25 14:15:35 Recruitment status
7 Update 2018/12/07 19:05:49 Recruitment status
8 Update 2018/12/07 19:07:03 Email
Organization
Organization
Address
Email
Institute
Institute
9 Update 2019/02/10 18:59:10 Last follow-up date
10 Update 2019/08/13 08:41:49 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Address
Address
TEL
Name of person sending information
Name of person sending information
Address
Address
TEL
Organization
Organization
Address
Address
Tel
Email
11 Update 2019/08/13 08:43:32 Number of participants that the trial has enrolled
12 Update 2019/08/13 08:50:13 Date of IRB
13 Update 2020/02/12 17:15:06 Last follow-up date
Date trial data considered complete
14 Update 2020/05/07 09:43:33 Last follow-up date
Date trial data considered complete
Date analysis concluded
15 Update 2024/02/19 12:56:24 Recruitment status
16 Update 2024/02/19 13:44:58 Acronym
Acronym
17 Update 2024/02/19 13:54:05 TEL
Email
Address